RxDoctor Payments Data

Amanda Rivera

Psychiatric/Mental Health · Buffalo, NYNPI 1568973618

Payments from drug & device makers

$926in general payments, 2019–2025

Across 55 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$246
  • Vanda Pharmaceuticals Inc.$151
  • Teva Pharmaceuticals USA, Inc.$132
  • Otsuka America Pharmaceutical, Inc.$105
  • Alkermes, Inc.$82
  • Noven Therapeutics, LLC$56
  • plus $154 from 5 others

What the payments were for

  • Food & beverage$926100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$926 in reported general payments places this provider in the 65th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York

Medicare billing

Part B allowed, 2024
$6,378
Medicare patients
16
Services billed
94

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CaplytaLumateperone Tosylate16$33,328
LybalviOlanzapine/Samidorphan Malate11$19,589
Bupropion XlBupropion Hcl23$1,368
Haloperidol Decanoate16$1,105
Olanzapine42$1,101
Quetiapine Fumarate52$1,075
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl11$670
Aripiprazole33$581
Fluoxetine Hcl80$560
Buspirone Hcl31$463
Venlafaxine Hcl ErVenlafaxine Hcl35$335
Hydroxyzine Hcl14$334
Trazodone Hcl50$321
Mirtazapine16$256
Prazosin Hcl18$248

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Alkermes, Inc.Lybalvi$82$19,58911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Buffalo

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →